Hepatitis C, Chronic – Page 2 – HCV Guidance

Disparities in absolute denial of modern hepatitis C therapy by type of insurance

September 6, 2017
Treatment with ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial

September 5, 2017
Hepatitis B virus reactivation associated with direct-acting antiviral therapy for chronic hepatitis C virus: a review of cases reported to the US Food and Drug Administration adverse event reporting system

September 4, 2017
Elbasvir-grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: a randomized trial

August 30, 2017
Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C

June 16, 2017
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C trial

June 16, 2017
NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents

June 16, 2017
Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women

June 16, 2017
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C

June 16, 2017
Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection

June 16, 2017